We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
According to a new report, intellectual property (IP)-intensive industries, such as computer and peripheral equipment, pharmaceutical and medicines, medical equipment, and semiconductor and other electronic components, were responsible in 2010, directly and indirectly, for 1 in 4 jobs in the United States and contributed more than $5 trillion to, or 34.8 percent of, the gross domestic product (GDP
The Food and Drug Administration (FDA) releases a final guide dated February 2012 titled “Guidance for Industry: Early Clinical Trials with Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information.”
